MerLion Pharmaceuticals Pte Ltd, Announces Collaboration Agreement with Sankyo Co., Ltd

25-Apr-2005

MerLion Pharmaceuticals Pte Ltd (MerLion) announced a three year drug discovery and development collaboration with Sankyo Co., Ltd. (Sankyo).

Under the collaboration, Sankyo will provide selected high throughput screens and additional assays to MerLion, who will provide access to its extensive sample collection and apply its screening and experienced natural products chemistry skills to the isolation of new chemical leads. MerLion and Sankyo will work in partnership throughout the lead discovery and optimisation stages of the collaboration. Sankyo will undertake clinical development and commercialisation of the discoveries.

"This agreement with Sankyo strengthens our existing relationships with Japan and key Japanese pharmaceutical companies" said Tony Buss, PhD, CEO of MerLion. "The partnership offers both Sankyo and MerLion unique opportunities to discover novel medicines from our diverse natural products chemistry and across a wide range of therapeutic areas."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances